Yıl: 2020 Cilt: 46 Sayı: 3 Sayfa Aralığı: 213 - 218 Metin Dili: İngilizce DOI: 10.5152/tud.2019.19051 İndeks Tarihi: 31-10-2020

Turkish Urologists’ preferences regarding antibiotic prophylaxis for transrectal prostate biopsy

Öz:
Objective: Antibiotic prophylaxis for transrectal prostate biopsy (PB) is very important in preventing infectious complications, and in this study, we aimed to evaluate the antibiotic preferences of Turkish urologist for transrectal PB.Material and methods: The survey about PB and antibiotic prophylaxis behaviors was administered to urologists working in Turkey who had previously participated in at least one international and one national congress.Results: A total of 237 urologists were included in the study. Antibiotic prophylaxis prior to PB was performed by 234 (98.7%) participants. Rectal swabbing prior to PB was not performed by 227 (95.8%) participants. The most common complication associated with PB was prostatitis (63%), followed by urinary tract infection (29%). Only 25.7% of Turkish urologists reported a single dose of antibiotic prophylaxis. Our participants often administered antibiotic prophylaxis for a period of 3, 5, or 7 days (16%, 21.1%, 35.9%, respectively). The most common antibiotic agent preferred for prophylaxis was ciprofloxacin (65%).Conclusion: The biopsy behavior of Turkish urologists was mostly compatible with the literature, but it was revealed that Turkish urologists do not prefer single-dose antibiotic therapy, and their practice patterns regarding the administration of pre-biopsy rectal swabbing are inconsistent with the literature.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Allemani C, Weir HK, Carreira H, Harewood R, Spika D, Wang XS, et al. Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet 2015;385:977-1010. [CrossRef]
  • 2. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin 2015;65:87-108. [CrossRef]
  • 3. Roberts MJ, Scott S, Harris PN, Naber K, Wagenlehner FME, Doi SAR. Comparison of fosfomycin against fluoroquinolones for transrectal prostate biopsy prophylaxis: an individual patient-data meta-analysis. World J Urol 2018;36:323-30. [CrossRef]
  • 4. Lundström KJ, Drevin L, Carlsson S, Garmo H, Loeb S, Stattin P, et al. Nationwide population-based study of infections after transrectal ultrasound guided prostate biopsy. J Urol 2014;192:1116-22. [CrossRef]
  • 5. Bruyere F, Malavaud S, Bertrand P, Decock A, Cariou G, Doublet JD, et al. Prosbiotate: a multicenter, prospective analysis of infectious complications after prostate biopsy. J Urol 2015;193:145-50. [CrossRef]
  • 6. Wagenlehner FME, van Oostrum E, Tenke P, Tandogdu Z, Çek M, Grabe M, et al. Infective complications after prostate biopsy: outcome of the Global Prevalence Study of Infections in Urology (GPIU) 2010 and 2011, a prospective multinational multicentre prostate biopsy study. Eur Urol 2013;63:521-7. [CrossRef]
  • 7. Cuevas O, Oteo J, Lázaro E, Aracil B, de Abajo F, García-Cobos S, et al. Significant ecological impact on the progression of fluoroquinolone resistance in Escherichia coli with increased community use of moxifloxacin, levofloxacin and amoxicillin/ clavulanic acid. J Antimicrob Chemother 2011;66:664-9. [CrossRef]
  • 8. Loeb S, Carter HB, Berndt SI, Ricker W, Schaeffer EM. Complications after prostate biopsy: data from SEER-Medicare. J Urol 2011;186:1830-4. [CrossRef]
  • 9. Smyth LG, Mulvin DW. Antibiotic prophylaxis for transrectal ultrasound biopsy of the prostate in Ireland. Ir J Med Sci 2012;181:33-5. [CrossRef]
  • 10. Rhodes NJ, Gardiner BJ, Neely MN, Grayson ML, Ellis AG, Lawrentschuk NT, et al. Optimal timing of oral fosfomycin administration for pre-prostate biopsy prophylaxis. J Antimicrob Chemother 2015;70:2068-73. [CrossRef]
  • 11. Kalkanlı A, Gezmiş CT, Özkan A, Çilesiz NC, Yanaral F, Aydın M, et al. Comparison of Single and Prolonged Fluoroquinolone Prophylaxis and Risk Factors for Infectious Complications After Transrectal Prostate Biopsy. Balkan Med J 2018;35:373-7. [CrossRef]
  • 12. Bulut V, Şahin AF, Balaban Y, Altok M, Divrik RT, Zorlu F. The efficacy of duration of prophylactic antibiotics in transrectal ultrasound guided prostate biopsy. Int Braz J Urol 2015;45:906-10. [CrossRef]
  • 13. Briffaux R, Coloby P, Bruyere B, Ouaki F, Pires C, Doré B, et al. One preoperative dose randomized against 3-day antibiotic prophylaxis for transrectal ultrasonography-guided prostate biopsy. BJU Int 2009;103:1069-73. [CrossRef]
  • 14. Farag M, Riddell S, Daffy J, Wong LM. Comparing infective complications from transrectal ultrasound guided prostate biopsy following transition to single dose oral ciprofloxacin prophylaxis. Investig Clin Urol 2019;60:54-60. [CrossRef]
  • 15. Pepdjonovic L, Tan GH, Huang S, Mann S, Frydenberg M, Moon D, et al. Zero hospital admissions for infection after 577 transperineal prostate biopsies using single-dose cephazolin prophylaxis. World J Urol 2017;35:1199-203. [CrossRef]
  • 16. Roberts MJ, Williamson DA, Hadway P, Doi SA, Gardiner RA, Paterson DL. Baseline prevalence of antimicrobial resistance and subsequent infection following prostate biopsy using empirical or altered prophylaxis: A bias-adjusted meta-analysis. Int J Antimicrob Agents 2014;43:301-9. [CrossRef]
  • 17. Boehm K, Siegel FP, Schneidewind L, Kranz J, Spachmann P, Frank T, et al. Antibiotic Prophylaxis in Prostate Biopsies: Contemporary Practice Patterns in Germany. Front Surg 2018;5:2. [CrossRef]
  • 18. Zowawi HM, Harris PN, Roberts MJ, Tambyah PA, Schembri MA, Pezzani MD, et al. The emerging threat of multidrug-resistant Gram-negative bacteria in urology. Nat Rev Urol 2015;12:570-84. [CrossRef]
  • 19. Bozcal E, Eldem V, Aydemir S, Skurnik M. The relationship between phylogenetic classification, virulence and antibiotic resistance of extraintestinal pathogenic Escherichia coli in İzmir province, Turkey. Peer J 2018;6:e5470. [CrossRef]
  • 20. Scott S, Harris PN, Williamson DA, Liss MA, Doi SAR, Roberts MJ. The effectiveness of targeted relative to empiric prophylaxis on infectious complications after transrectal ultrasound-guided prostate biopsy: a meta-analysis. World J Urol 2018;36:1007-17. [CrossRef]
  • 21. Tukenmez TE, Tandogdu Z, Ergonul O, Altinkanat G, Gunaydin B, Ozgen M, et al. Outcomes of Fecal Carriage of Extended-spectrum beta-Lactamase After Transrectal Ultrasound-guided Biopsy of the Prostate. Urology 2014;84:1008-15. [CrossRef]
  • 22. Salomon G, Prues S, Saul J, Schneider M, Budäus L, Tilki, et al. Antimicrobial lubricant reduces rectal bacteria at transrectal prostate biopsy. Results from a large prospective randomized trial. Eur Urol Suppl 2017;16:e1090-1. [CrossRef]
  • 23. Batura D, Rao GG. The national burden of infections after prostate biopsy in England and Wales: a wake-up call for better prevention. J Antimicrob Chemother 2013;68:247-9. [CrossRef]
  • 24. Cam K, Kayikci A, Akman Y, Erol A. Prospective assessment of the efficacy of single dose versus traditional 3-day antimicrobial prophylaxis in 12-core transrectal prostate biopsy. Int J Urol 2008;15:997-1001. [CrossRef]
  • 25. Carmignani L, Picozzi S, Spinelli M, Di Pierro S, Mombelli G, Negri E, et al. Bacterial sepsis following prostatic biopsy. Int Urol Nephrol 2012;44:1055-63. [CrossRef]
  • 26. Zani EL, Clark OA, Rodrigues Netto Jr N. Antibiotic prophylaxis for transrectal prostate biopsy. Cochrane Database Syst Rev 2011;11:CD006576. [CrossRef]
  • 27. Yang M, Zhao X, Wu Z, Xiao N, Lu C. Meta-analysis of antibiotic prophylaxis use in transrectal prostatic biopsy. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2009;34:115-23.
  • 28. American Urological Association. Best practice policy statement on urologic surgery antimicrobial prophylaxis. American Urological Association Web site. https://www.auanet.org/guidelines/antimicrobial-prophylaxis-(2008-reviewed-and-validity-confirmed-2011-amended-2012). Accessed November 16, 2018.
  • 29. Lee JE, Shin SS, Kang TW, Kim JW, Heo SH, Jeong YY. Comparison of Different Rectal Cleansing Methods for Reducing Post-Procedural Infectious Complications After Transrectal Ultrasound-Guided Prostate Biopsy. Urol J 2019 Mar 18. DOI: 10.22037/uj.v0i0.4583. [Epub ahead of print]
  • 30. European Association of Urology. Urological Infections. Prostate Biopy. European Association of Urology web site. http://uroweb.org/guideline/urological-infections/#note_360. Accessed November 15, 2018.
APA Demirtaş A, Eryilmaz-Eren E, Sönmez G, Tombul S, Alp E, BİOPSY T (2020). Turkish Urologists’ preferences regarding antibiotic prophylaxis for transrectal prostate biopsy. , 213 - 218. 10.5152/tud.2019.19051
Chicago Demirtaş Abdullah,Eryilmaz-Eren Esma,Sönmez Gökhan,Tombul Sevket Tolga,Alp Emine,BİOPSY Turkish Urology Academy Study Group of Prostate Turkish Urologists’ preferences regarding antibiotic prophylaxis for transrectal prostate biopsy. (2020): 213 - 218. 10.5152/tud.2019.19051
MLA Demirtaş Abdullah,Eryilmaz-Eren Esma,Sönmez Gökhan,Tombul Sevket Tolga,Alp Emine,BİOPSY Turkish Urology Academy Study Group of Prostate Turkish Urologists’ preferences regarding antibiotic prophylaxis for transrectal prostate biopsy. , 2020, ss.213 - 218. 10.5152/tud.2019.19051
AMA Demirtaş A,Eryilmaz-Eren E,Sönmez G,Tombul S,Alp E,BİOPSY T Turkish Urologists’ preferences regarding antibiotic prophylaxis for transrectal prostate biopsy. . 2020; 213 - 218. 10.5152/tud.2019.19051
Vancouver Demirtaş A,Eryilmaz-Eren E,Sönmez G,Tombul S,Alp E,BİOPSY T Turkish Urologists’ preferences regarding antibiotic prophylaxis for transrectal prostate biopsy. . 2020; 213 - 218. 10.5152/tud.2019.19051
IEEE Demirtaş A,Eryilmaz-Eren E,Sönmez G,Tombul S,Alp E,BİOPSY T "Turkish Urologists’ preferences regarding antibiotic prophylaxis for transrectal prostate biopsy." , ss.213 - 218, 2020. 10.5152/tud.2019.19051
ISNAD Demirtaş, Abdullah vd. "Turkish Urologists’ preferences regarding antibiotic prophylaxis for transrectal prostate biopsy". (2020), 213-218. https://doi.org/10.5152/tud.2019.19051
APA Demirtaş A, Eryilmaz-Eren E, Sönmez G, Tombul S, Alp E, BİOPSY T (2020). Turkish Urologists’ preferences regarding antibiotic prophylaxis for transrectal prostate biopsy. Turkish Journal of Urology, 46(3), 213 - 218. 10.5152/tud.2019.19051
Chicago Demirtaş Abdullah,Eryilmaz-Eren Esma,Sönmez Gökhan,Tombul Sevket Tolga,Alp Emine,BİOPSY Turkish Urology Academy Study Group of Prostate Turkish Urologists’ preferences regarding antibiotic prophylaxis for transrectal prostate biopsy. Turkish Journal of Urology 46, no.3 (2020): 213 - 218. 10.5152/tud.2019.19051
MLA Demirtaş Abdullah,Eryilmaz-Eren Esma,Sönmez Gökhan,Tombul Sevket Tolga,Alp Emine,BİOPSY Turkish Urology Academy Study Group of Prostate Turkish Urologists’ preferences regarding antibiotic prophylaxis for transrectal prostate biopsy. Turkish Journal of Urology, vol.46, no.3, 2020, ss.213 - 218. 10.5152/tud.2019.19051
AMA Demirtaş A,Eryilmaz-Eren E,Sönmez G,Tombul S,Alp E,BİOPSY T Turkish Urologists’ preferences regarding antibiotic prophylaxis for transrectal prostate biopsy. Turkish Journal of Urology. 2020; 46(3): 213 - 218. 10.5152/tud.2019.19051
Vancouver Demirtaş A,Eryilmaz-Eren E,Sönmez G,Tombul S,Alp E,BİOPSY T Turkish Urologists’ preferences regarding antibiotic prophylaxis for transrectal prostate biopsy. Turkish Journal of Urology. 2020; 46(3): 213 - 218. 10.5152/tud.2019.19051
IEEE Demirtaş A,Eryilmaz-Eren E,Sönmez G,Tombul S,Alp E,BİOPSY T "Turkish Urologists’ preferences regarding antibiotic prophylaxis for transrectal prostate biopsy." Turkish Journal of Urology, 46, ss.213 - 218, 2020. 10.5152/tud.2019.19051
ISNAD Demirtaş, Abdullah vd. "Turkish Urologists’ preferences regarding antibiotic prophylaxis for transrectal prostate biopsy". Turkish Journal of Urology 46/3 (2020), 213-218. https://doi.org/10.5152/tud.2019.19051